Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2019

Open Access 01-12-2019 | Antidepressant Drugs | Research article

A retrospective comparison of inappropriate prescribing of psychotropics in three Norwegian nursing homes in 2000 and 2016 with prescribing quality indicators

Authors: Jan Schjøtt, Jörg Aßmus

Published in: BMC Medical Informatics and Decision Making | Issue 1/2019

Login to get access

Abstract

Background

Inappropriate prescribing of psychotropics is a persistent and prevalent problem in nursing homes. The present study compared inappropriate prescribing of psychotropics in nursing homes 16 years apart with prescribing quality indicators. The purpose was to identify any change in inappropriate prescribing of relevance for medical informatics.

Methods

Three Norwegian nursing homes were audited in 2000 and 2016 with regard to prescribing quality. Psychotropics among 386 patients in 2000, and 416 patients in 2016, included combinations of antidepressants, antipsychotics, anxiolytics-hypnotics, and antiepileptics. Prescribing quality indicators included psychotropic polypharmacy (defined as concurrent use of three or more psychotropics) and potential inappropriate psychotropic substances or combinations. Furthermore, potential clinically relevant psychotropic interactions were classified as pharmacodynamic or pharmacokinetic using an interaction database. The first ranked (most important) interaction in each patient was selected with the following importance of categories in the database; recommended action > documentation > severity. Three levels (from low to high) within each category were used for ranking.

Results

From 2000 to 2016, psychotropic polypharmacy increased from 6.2 to 29.6%, potential inappropriate psychotropic substances was reduced from 17.9 to 11.3% and potential inappropriate psychotropic combinations increased from 7.8 to 27.9%. Changes in polypharmacy and combinations were predominantly associated with prescribing of anxiolytics-hypnotics. Sixty-three patients (16.3%) had psychotropic interactions in 2000 increasing to 146 patients (35.1%) in 2016. The increase in interactions was associated with prescribing of antidepressants. First ranked interactions, more than 60% of all interactions in both years, were increasingly pharmacodynamic, from 69.9 to 91.0%. Interactions in 2016 were associated with a lower level of recommended action and documentation, but not severity compared to 2000. The inappropriate prescribing of antipsychotics and antiepileptics was reduced in 2016 compared to 2000.

Conclusions

Using prescribing quality indicators we observed the importance of antidepressants and anxiolytics-hypnotics for inappropriate prescribing in 2016 while the role of antipsychotics and antiepileptics were reduced compared to 2000. A change to mainly pharmacodynamic interactions that lack good documentation was also observed. The present findings can be used for medical informatics-based approaches to address specific problems with prescribing, and prescribing quality indicators, in Norwegian nursing homes.
Literature
1.
go back to reference Pitkala KH, Laurila JV, Strandberg TE, Tilvis RS. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriat. 2004;16:61–74.CrossRef Pitkala KH, Laurila JV, Strandberg TE, Tilvis RS. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriat. 2004;16:61–74.CrossRef
2.
go back to reference Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25:683–92.CrossRef Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008;25:683–92.CrossRef
3.
go back to reference Olsson J, Bergman A, Carlsten A, Oké T, Bernsten C, Schmidt IK, et al. Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig. 2010;30:289–300.CrossRef Olsson J, Bergman A, Carlsten A, Oké T, Bernsten C, Schmidt IK, et al. Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig. 2010;30:289–300.CrossRef
4.
go back to reference Selbaek G, Kirkevold Ø, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry. 2007;22:843–9.CrossRef Selbaek G, Kirkevold Ø, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry. 2007;22:843–9.CrossRef
5.
go back to reference Selbaek G, Kirkevold Ø, Engedal K. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study. Am J Geriatr Psychiatry. 2008;16:528–36.CrossRef Selbaek G, Kirkevold Ø, Engedal K. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study. Am J Geriatr Psychiatry. 2008;16:528–36.CrossRef
6.
go back to reference Halvorsen KH, Granas AG, Engeland A, Ruths S. Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs. Pharmacoepidemiol Drug Saf. 2012;21:929–36.CrossRef Halvorsen KH, Granas AG, Engeland A, Ruths S. Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs. Pharmacoepidemiol Drug Saf. 2012;21:929–36.CrossRef
7.
go back to reference Halvorsen KH, Selbaek G, Ruths S. Trends in potentially inappropriate medication prescribing to nursing home patients: comparison of three cross-sectional studies. Pharmacoepidemiol Drug Saf. 2017;26:192–200.CrossRef Halvorsen KH, Selbaek G, Ruths S. Trends in potentially inappropriate medication prescribing to nursing home patients: comparison of three cross-sectional studies. Pharmacoepidemiol Drug Saf. 2017;26:192–200.CrossRef
8.
go back to reference Herr M, Grondin H, Sanchez S, Armaingaud D, Blochet C, Vial A, et al. Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France. Eur J Clin Pharmacol. 2017;73:601–8.CrossRef Herr M, Grondin H, Sanchez S, Armaingaud D, Blochet C, Vial A, et al. Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France. Eur J Clin Pharmacol. 2017;73:601–8.CrossRef
12.
go back to reference Lesén E, Petzold M, Andersson K, Carlsted A. To what extent does the indicator “concurrent use of three or more psychotropic drugs” capture use of potentially inappropriate psychotropics among the elderly? Eur J Clin Pharmacol. 2009;65:635–42.CrossRef Lesén E, Petzold M, Andersson K, Carlsted A. To what extent does the indicator “concurrent use of three or more psychotropic drugs” capture use of potentially inappropriate psychotropics among the elderly? Eur J Clin Pharmacol. 2009;65:635–42.CrossRef
13.
go back to reference Sweidan M, Reeve JF, Brien JA, Jayasuriya P, Martin JH, Vernon GM. Quality of drug interaction alerts in prescribing and dispensing software. Med J Aust. 2009;190:251–4.PubMed Sweidan M, Reeve JF, Brien JA, Jayasuriya P, Martin JH, Vernon GM. Quality of drug interaction alerts in prescribing and dispensing software. Med J Aust. 2009;190:251–4.PubMed
14.
go back to reference Kongsholm GG, Nielsen AK, Damkier P. Drug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic review. Eur J Clin Pharmacol. 2015;71:1397–402.CrossRef Kongsholm GG, Nielsen AK, Damkier P. Drug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic review. Eur J Clin Pharmacol. 2015;71:1397–402.CrossRef
17.
go back to reference Pugh MJ, Knoefel JE, Mortensen EM, Amuan ME, Berlowitz DR, Van Cott AC. New-onset epilepsy risk factors in older veterans. J Am Geriat Soc. 2009;57:237–42.CrossRef Pugh MJ, Knoefel JE, Mortensen EM, Amuan ME, Berlowitz DR, Van Cott AC. New-onset epilepsy risk factors in older veterans. J Am Geriat Soc. 2009;57:237–42.CrossRef
18.
go back to reference Dörks M, Schmiemann G, Hoffmann F. Pro re nata (as needed) medication in nursing homes: the longer you stay, the more you get? Eur J Clin Pharmacol. 2016;72:95–101.CrossRef Dörks M, Schmiemann G, Hoffmann F. Pro re nata (as needed) medication in nursing homes: the longer you stay, the more you get? Eur J Clin Pharmacol. 2016;72:95–101.CrossRef
20.
go back to reference Scheife RT, Hines LE, Boyce RD, Chung SP, Momper JD, Sommer CD, et al. Consensus Recommendations for Systematic Evaluation of Drug-Drug Interaction Evidence for Clinical Decision Support. Drug Saf. 2015;38:197–206.CrossRef Scheife RT, Hines LE, Boyce RD, Chung SP, Momper JD, Sommer CD, et al. Consensus Recommendations for Systematic Evaluation of Drug-Drug Interaction Evidence for Clinical Decision Support. Drug Saf. 2015;38:197–206.CrossRef
21.
go back to reference Tilson H, Hines LE, McEvoy G, Weinstein DM, Hansten PD, Matuszewski K, et al. Recommendations for selecting drug–drug interactions for clinical decision support. Am J Health Syst Pharm. 2016;73:576–85.CrossRef Tilson H, Hines LE, McEvoy G, Weinstein DM, Hansten PD, Matuszewski K, et al. Recommendations for selecting drug–drug interactions for clinical decision support. Am J Health Syst Pharm. 2016;73:576–85.CrossRef
22.
go back to reference Strasberg HR, Chan A, Sklar SJ. Inter-rater agreement among physicians on the clinical significance of drug-drug interactions. AMIA Annu Symp Proc. 2013;2013:1325–8.PubMedPubMedCentral Strasberg HR, Chan A, Sklar SJ. Inter-rater agreement among physicians on the clinical significance of drug-drug interactions. AMIA Annu Symp Proc. 2013;2013:1325–8.PubMedPubMedCentral
23.
go back to reference van Noord C, Eijgelsheim M, Stricker BHCH. Drug- and non-drug-associated QT interval prolongation. Br J Clin Pharmacol. 2010;70:16–2.CrossRef van Noord C, Eijgelsheim M, Stricker BHCH. Drug- and non-drug-associated QT interval prolongation. Br J Clin Pharmacol. 2010;70:16–2.CrossRef
24.
go back to reference Hondeghem LM. Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation? Drug Saf. 2018;41:11–7.CrossRef Hondeghem LM. Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation? Drug Saf. 2018;41:11–7.CrossRef
25.
go back to reference Niemeijer MN, van den Berg ME, Franco OH, Hofman A, Kors JA, Stricker BH, et al. Drugs and ventricular repolarization in a general population: the Rotterdam Study. Pharmacoepidemiol Drug Saf. 2015;24:1036–41.CrossRef Niemeijer MN, van den Berg ME, Franco OH, Hofman A, Kors JA, Stricker BH, et al. Drugs and ventricular repolarization in a general population: the Rotterdam Study. Pharmacoepidemiol Drug Saf. 2015;24:1036–41.CrossRef
26.
go back to reference Riad FS, Davis AM, Moranville MP, Beshai JF. Drug-Induced QTc Prolongation. Am J Cardiol. 2017;119:280–3.CrossRef Riad FS, Davis AM, Moranville MP, Beshai JF. Drug-Induced QTc Prolongation. Am J Cardiol. 2017;119:280–3.CrossRef
27.
go back to reference Fanoe S, Kristensen D, Fink-Jensen A, Jensen HK, Toft E, Nielsen J, et al. Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management. Eur Heart J. 2014;35:1306–15.CrossRef Fanoe S, Kristensen D, Fink-Jensen A, Jensen HK, Toft E, Nielsen J, et al. Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management. Eur Heart J. 2014;35:1306–15.CrossRef
28.
go back to reference Hasnain M, Vieweg WV. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review. CNS Drugs. 2014;28:887–920.CrossRef Hasnain M, Vieweg WV. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review. CNS Drugs. 2014;28:887–920.CrossRef
30.
go back to reference Judge J, Field TS, DeFlorio M, Laprino J, Auger J, Rochon P, et al. Prescribers’ responses to alerts during medication ordering in the long term care setting. Am Med Inform Assoc. 2006;13:385–90.CrossRef Judge J, Field TS, DeFlorio M, Laprino J, Auger J, Rochon P, et al. Prescribers’ responses to alerts during medication ordering in the long term care setting. Am Med Inform Assoc. 2006;13:385–90.CrossRef
31.
go back to reference Bryant AD, Fletcher GS, Payne TH. Drug Interaction Alert Override Rates in the Meaningful Use Era. No Evidence of Progress. Appl Clin Inform. 2014;5:802–13.CrossRef Bryant AD, Fletcher GS, Payne TH. Drug Interaction Alert Override Rates in the Meaningful Use Era. No Evidence of Progress. Appl Clin Inform. 2014;5:802–13.CrossRef
33.
go back to reference Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population a randomised controlled trial. J Gerontol A Biol Sci Med Sci. 2013;68:271–8.CrossRef Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population a randomised controlled trial. J Gerontol A Biol Sci Med Sci. 2013;68:271–8.CrossRef
35.
go back to reference Ruths S, Sørensen PH, Kirkevold Ø, Husebø BS, Krüger K, Halvorsen KH, et al. Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts. Int J Geriatr Psychiatry. 2013;28:868–76.CrossRef Ruths S, Sørensen PH, Kirkevold Ø, Husebø BS, Krüger K, Halvorsen KH, et al. Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts. Int J Geriatr Psychiatry. 2013;28:868–76.CrossRef
38.
go back to reference Selbæk G, Janus SIM, Bergh S, Engedal K, Ruths S, Helvik AS, et al. Change in psychotropic drug use in Norwegian nursing homes between 2004 and 2011. Int Psychogeriatr. 2017;29:1–10. Selbæk G, Janus SIM, Bergh S, Engedal K, Ruths S, Helvik AS, et al. Change in psychotropic drug use in Norwegian nursing homes between 2004 and 2011. Int Psychogeriatr. 2017;29:1–10.
39.
go back to reference Gaboda D, Lucas J, Siegel M, Kalay E, Crystal S. No longer undertreated? Depression diagnosis and antidepressant therapy in elderly long-stay nursing home residents, 1999 to 2007. J Am Geriatr Soc. 2011;59:673–80.CrossRef Gaboda D, Lucas J, Siegel M, Kalay E, Crystal S. No longer undertreated? Depression diagnosis and antidepressant therapy in elderly long-stay nursing home residents, 1999 to 2007. J Am Geriatr Soc. 2011;59:673–80.CrossRef
40.
go back to reference Liperoti R, Onder G, Landi F, Lapane KL, Mor V, Bernabei R, et al. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry. 2009;70:1340–7.CrossRef Liperoti R, Onder G, Landi F, Lapane KL, Mor V, Bernabei R, et al. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry. 2009;70:1340–7.CrossRef
43.
go back to reference Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27:153–9.CrossRef Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27:153–9.CrossRef
Metadata
Title
A retrospective comparison of inappropriate prescribing of psychotropics in three Norwegian nursing homes in 2000 and 2016 with prescribing quality indicators
Authors
Jan Schjøtt
Jörg Aßmus
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2019
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-019-0821-0

Other articles of this Issue 1/2019

BMC Medical Informatics and Decision Making 1/2019 Go to the issue